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In 2010, an estimated 25% of disability-adjusted life-years—a metric that incorporates 
premature death by years of life lost and years lived with disability—and 13% of all deaths 
worldwide were in children younger than 5 years.1,2 While reductions in mortality in 
children younger than 5 years have occurred in many countries since 1990, mortality 
increased in young children in some parts of sub-Saharan Africa, with severe infections 
leading to sepsis being a major contributor.1 For instance, in the neonatal period, diarrhea, 
lower respiratory tract infections, and meningitis were important contributors to mortality in 
2010, while in the postneonatal period, nearly 1 million estimated deaths (half of all deaths) 
were due to lower respiratory tract infections (respiratory syncytial virus, Haemophilus 
influenzae type B, Streptococcus pneumoniae), diarrheal diseases (rotavirus, 
Cryptosporidium), and malaria.2 Other infectious causes of death in children younger than 5 
years were measles, pertussis, and human immunodeficiency virus/AIDS. We suggest that 
sepsis-related pediatric deaths are substantially underestimated and that efforts are needed to 
better assess the impact of sepsis on childhood mortality worldwide.
The Surviving Sepsis Campaign defines sepsis as the presence of infection together with 
systemic manifestations of infection; sepsis-induced organ dysfunction or tissue 
hypoperfusion is referred to as severe sepsis.3 The common pathway to death for most 
children with systemic signs and symptoms associated with bacterial or viral infections is 
sepsis, whether death occurs at home or in a health care facility. These infections can result 
in a systemic inflammatory response and progress to severe sepsis and septic shock, often 
leading to multiorgan failure and death; survivors may have significant disabilities.4,5 
However, for the Global Burden of Disease Study 2010 estimates, sepsis as a cause of death 
is considered only for neonatal deaths.2,6 Although this is likely due to a lack of data, such 
estimates underestimate the contribution of sepsis to mortality in the postneonatal period and 
in children aged 1 to 4 years. It is important to classify deaths according to specific causes as 
these data are needed for crafting and deploying preventive measures such as bed nets for 
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malaria-endemic areas and vaccines such as for measles and pertussis. However, when faced 
with a child with severe multiorgan illness and systemic signs and symptoms of an infection, 
it is important to emphasize that the unifying feature of nearly all of these deaths is that they 
are due to sepsis.
Severe infections lead to systemic symptoms and organ dysfunction, which if untreated lead 
to death and disability. Moreover, pneumonia, diarrhea, malaria, and mixed infections 
commonly coexist; thus, there is considerable overlap of symptoms and organ involvement 
regardless of the etiologic agent. As a consequence, the clinician is faced with signs and 
symptoms consistent with syndromic sepsis, and practical interventions and pragmatic 
processes addressing sepsis can lead to greater efficiency and reduced deaths and disability 
as compared with focusing on specific infectious agents. From the clinician’s viewpoint, a 
diagnosis of sepsis recognizes that children who die of infections, regardless of their source, 
develop various combinations of septic shock, cardiac failure, acute respiratory distress 
syndrome, or other organ dysfunction. This is the overwhelming experience in resource-rich 
countries such as the United States and Australia where infections leading to sepsis and 
septic shock confer a high burden of disease and mortality in pediatric intensive care units.
4,5
 Moreover, generic support for the underlying pathophysiology in patients with sepsis 
syndrome has resulted in marked improvements in outcomes in resource-rich areas and, with 
a similar approach, may also do so in resource-poor areas. Indeed, the largest study of 
children with severe febrile illness and impaired perfusion in sub-Saharan Africa supports 
this contention in that all deaths were due to a combination of severe shock and acidosis 
with or without respiratory and neurological dysfunction.7
Highlighting sepsis as the result of severe illness from infections is important for ensuring 
provision of appropriate timely supportive care, especially in resource-limited environments 
where the disease burden is high and early intervention may circumvent multiorgan failure 
that demands resources such as ventilators or dialysis machines that are not available. 
Moreover, skilled health care workers are in short supply and care is being delivered by 
teams with limited training and clinical skills; the syndromic sepsis approach lends itself to a 
simple generic protocol for recognition and treatment that can be taught and implemented 
even in austere settings. Another common issue is the lack of laboratory services for 
microbiological diagnoses. Hence, highlighting severe illness with systemic signs and 
symptoms triggered by infections as sepsis helps the clinician because there is greater 
reliance on clinical acumen and less emphasis on laboratory pathogen confirmation. Indeed, 
the most important interventions to reduce sepsis morbidity and mortality must be made 
before a specific pathogen diagnosis is available.
That invasive infections lead to sepsis, severe sepsis, and septic shock is supported by 
clinical and robust pathophysiological evidence. It is often difficult to separate the 3 most 
common causes of death (pneumonia, malaria, and diarrheal diseases) in children with 
certainty in low-resource settings. These conditions often coexist and, when severe, lead to 
sepsis and septic shock. For instance, cerebral malaria is commonly associated with 
pneumonia, invasive bacterial infection is common in malaria, and pneumonia and diarrhea 
often occur concurrently in children in low-resource countries. A child presenting in septic 
shock may have pneumonia, malaria, or other invasive bacterial infection. Many children 
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with gastroenteritis die of dehydration and electrolyte disturbances. However, those who fail 
to improve after intravascular volume replacement and correction of electrolyte 
abnormalities are also likely to have a bacterial superinfection and sepsis. Thus, an approach 
by clinicians to manage the complex syndrome (severe sepsis) is indicated. The Surviving 
Sepsis Campaign international guidelines3 address the role of antimicrobials (if available).
In most cases, identification of the specific etiologic agent(s) is not needed for initial 
management of children with sepsis. Separation into clinical syndromes is best made on 
clinical grounds and can signify the site of infection such as pneumonia or meningitis in 
some cases. However, the initial treatment options for most severe infections leading to 
sepsis are also limited and should include broad-spectrum antimicrobial administration, fluid 
administration (based on intravascular volume status), blood products (based on hemoglobin 
and platelet levels), oxygen administration (based on oxygenation status), and close 
monitoring. Thus, clinical management will be very similar—with minor variation in broad-
spectrum antimicrobial choices based on cost and availability. Labeling pediatric sepsis as 
the final common pathway leading to critical illness and death from most infectious agents 
in resource-limited areas also simplifies educational materials and treatment protocols for 
health care workers with limited skills. The World Health Organization guidelines on 
integrated management of childhood illness use this approach by highlighting danger signs 
and therapies rather than specific diseases, thus highlighting sepsis and the emergency 
therapeutic interventions needed for treatment.
Given the efforts by the Surviving Sepsis Campaign to reduce sepsis-related deaths in all 
ages worldwide,3 baseline estimates of sepsis-related deaths are needed to measure the 
success of such interventions. Therefore, we urge investigators who are assessing global 
mortality from infectious diseases to consider incorporating estimates of sepsis-related 
mortality for children of all ages.
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